EFEXOR Tablets 37.5mg Milligram
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
30-04-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
VENLAFAXINE HYDROCHLORIDE
थमां उपलब्ध:
PCO Manufacturing
डोज़:
37.5mg Milligram
फार्मास्यूटिकल फॉर्म:
Tablets
प्राधिकरण की तारीख:
0000-00-00
उत्पाद विशेषताएं
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Efexor 37.5mg Tablets.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 37.5 mg of venlafaxine (as hydrochloride).
Excipients:
Lactose
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
_Product imported from Greece:_
Peach coloured, shield shaped tablet impressed with the tablet strength ‘37.5’ and embossed with a ‘W’ on one face,
and plain on the other.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Efexor is indicated for the treatment of depressive illness in both hospitalised patients and outpatients, including
depression accompanied by anxiety.
Following an initial response Efexor is indicated for the prevention of relapses of the initial episode of depression or for
the prevention of the recurrence of new episodes.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_Adults:_
The usual recommended dose is 75mg per day given in two divided doses (37.5mg twice daily). If, after several weeks,
further clinical improvement is required, the dose may be increased to 150mg per day given in two divided doses
(75mg twice daily).
If, in the judgement of the physician, a higher dose is required, for example in more severely depressed or hospitalised
patients, a starting dose of 150mg per day may be given in two divided doses (75mg twice daily). The daily dose may
then be increased by up to 75mg every two or three days until the desired response is achieved. The maximum
recommended dose is 375mg per day. The dose should then be gradually reduced to the usual dosage, consistent with
patient response and tolerance.
Usually, the dosage for prevention of relapse or for prevention of recurrence of a new episode is similar to that used
during the index episod
पूरा दस्तावेज़ पढ़ें
